Controversies in Renal Replacement Therapy for Acute Kidney Injury

Participants will learn about the most current evidence around the prescription of renal replacement therapy for patients with acute kidney injury. They will also acquire an appreciation of the risks associated with an episode of acute kidney injury that may persist well after hospital discharge.

Learning Objectives: 

After participation in this activity, learners will be better able to:

  • Discuss the current evidence base for pre-emptive vs watchful waiting strategies in the initiation of renal replacement therapy for acute kidney injury
  • Identify an evidence-based approach for the prescription of renal replacement therapy in acute kidney injury
  • Discuss strategies that might improve the outcomes of patients discharged from hospital after an episode of acute kidney injury

Target Audience

  • Physician
  • Pharmacist
Accreditation/Designation of Credit Statements:

In support of improving patient care, the National Kidney Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician

The National Kidney Foundation designates this online CME/CE for a maximum of 1.5 AMA PRA Category 1 Credit(s) TMPhysicians should claim only the credit commensurate with the extent of their participation in the activity. 

Pharmacist

This knowledge-based enduring activity has been assigned ACPE Universal Activity Number
0620-0000-17-035-H01-P, for 1.5 contact hours (0.15 CEUs). The activity is available for credit through October 18, 2019. To receive credit, learners must review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; complete the pre-test; complete the post-test (minimum score of 70% required) and electronic evaluation.  An NABP eProfile ID and date of birth in MMDD format are prerequisites for receiving continuing pharmacy education credits. All ACPE credit awarded to participants must be uploaded to CPE Monitor™ within 30 days of the activity date, so pharmacists and pharmacy technicians are required to provide their e-Profile ID and date of birth (MMDD) at the time of the activity.  Please contact cmeinfo@kidney.org if you do not see activity information listed in your profile within 30 days.  For more information and to set up your e-Profile visit: www.MyCPEmonitor.net.

Method of Participation:

Learners will review the materials on accreditation information, target audience, learning objectives, and disclosure information; participate in the entire self-study consisting of slides and audio; and complete the post-test (minimum score of 70% required; learners will only have 3 attempts to pass the post-test) and evaluation to successfully earn credit. The estimated time for completion is 1.5 hours. To receive AMA PRA Category 1 Credit(s)™, participants must receive a minimum score of 70% on the post-test.     

If you participated in the live symposium Controversies in Renal Replacement Therapy for Acute Kidney Injury on Thursday, April 20, 2017 and claimed credit, you should not claim credit for this endured activity.

Declaration of Disclosure:

It is the policy of the National Kidney Foundation (NKF) to ensure balance, independence, objectivity, and scientific rigor in all CME/CE activities. Any individual who has control over CME/CE content is required to disclose to learners prior to the activity any relevant financial relationship(s) they may have with commercial interests supporting this activity or whose products or devices are discussed in this activity.  

If, on the basis of information disclosed, a perceived conflict exists, resolution will be achieved based on NKF's Disclosure and Conflict of Interest Policy.

Unlabeled/Investigational Use:

During their presentations, faculty may discuss an unlabeled use or an investigational use not approved for a commercial product. Each faculty member is required to disclose this information to the audience when referring to an unlabeled or investigational use.

Disclaimer:

The faculty and National Kidney Foundation (NKF) do not recommend the use of any pharmaceutical, diagnostic test, or device outside of the labeled indications as approved by the FDA. Please refer to the official prescribing information for each product for approved indications, contraindications, and warnings.

Information contained in this NKF educational resource is based upon current data available at the time of publication. Information is intended to help clinicians become aware of new scientific findings and developments.  This NKF educational resource is not intended to set out a preferred standard of care and should not be construed as one. Neither should the information be interpreted as prescribing an exclusive course of management.

Variations in practice will inevitably and appropriately occur when clinicians take into account the needs of individual patients, available resources, and limitations unique to an institution or type of practice. Every healthcare professional making use of information in this NKF educational resource is responsible for interpreting the data as it pertains to clinical decision making in each individual patient.

Course summary
Available credit: 
  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance
Course opens: 
10/18/2017
Course expires: 
10/18/2019
Cost:
$35.00
Rating: 
0
Faculty Disclosures:

Ron Wald, MDCM, MPH
Staff Physician         
St. Michael's Hospital       
ON, Canada
Disclosure: The speaker has received research funds and an honorarium from Baxter and Durect respectively, in the subject of AKI.

Paul Palevsky, MD
Chief, Renal Section (VA) & Professor of Medicine 
University of Pittsburgh School of Medicine
Pittsburgh, PA       
Disclosure:
The speaker received a consulting fee from Baxter in the subject of Acute Kidney Injury

Sean Bagshaw, MD, MSc, FRCPC
Associate Professor    
University of Alberta
Edmonton, AB
Disclosure: The speaker received consulting fees, industry sponsored grant from Sanofi Genzyme in the subject of Fabry Disease, consulting fees from Baxter Healthcare
Corp in the subject of Peritoneal Dialysis and Telemedicine

Planning Committee Disclosures:

Dena Rifkin, MD, MS, FNKF
Physician
VA San Diego
La Jolla, CA
Disclosure: Has no financial relationships with commercial interest(s).

Laurence Beck, Jr., MD, PhD.
Associate Professor of Medicine
Boston University School of Medicine
Boston, MA
Disclosure: The speaker research support from Pfizer CTI, and an honoraria from UpToDate, both for the subject of membranous nephropathy.

Thomas Nolin, PharmD, PhD
Associate Professor
University of Pittsburgh School of Pharmacy
Pittsburgh, PA
Disclosure: The speaker received consulting fees and travel from AM Pharma and Thrasos Innovation, Inc in the subject of AKI for their role as a consultant and IDMC member, respectively.

Danielle Nathan, MA
Professional Education Director
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Kathryn Troy, MPH
Professional Education Coordinator
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Nathalie Harden
Director, CME
National Kidney Foundation
New York, NY
Disclosure: Has no financial relationships with commercial interest(s).

Available Credit

  • 1.50 ACPE Contact Hours
  • 1.50 AMA PRA Category 1 Credit™
  • 1.50 Attendance

Accreditation Period

Course opens: 
10/18/2017
Course expires: 
10/18/2019

Price

Cost:
$35.00
Please login or register for a PERC account to take this course.

Required Hardware/software

System requirements can be found here.

Contact Information:

For any questions concerning this activity, please send an email to CMEinfo@kidney.org or call NKF at 1-800-622-9010.

To view NKF privacy and confidentiality policy as it relates to CME/CE activity, please visit http://www.kidney.org/

For additional professional education resources, contact NKF at 1-800-622-9010 or visit https://www.kidney.org/professionals